Protagonist Therapeutics
PTGX
PTGX
270 hedge funds and large institutions have $3.92B invested in Protagonist Therapeutics in 2025 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 119 increasing their positions, 76 reducing their positions, and 49 closing their positions.
Holders
270
Holders Change
-4
Holders Change %
-1.46%
% of All Funds
3.63%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
50
Increased
119
Reduced
76
Closed
49
Calls
$11.6M
Puts
$15.9M
Net Calls
-$4.31M
Net Calls Change
-$23.5M
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$138M |
| 2 |
CC
2
Commodore Capital
New York
|
$59.4M |
| 3 |
3
Adage Capital Partners
Boston,
Massachusetts
|
$60.4M |
| 4 |
BI
4
BVF Inc
San Francisco,
California
|
$177M |
| 5 |
5
Holocene Advisors
New York
|
$29.3M |
